APA
Yasuda E., Kumada T., Toyoda H., Kaneoka Y., Maeda A., Okuda S., Yoshimi N. & Kozawa O. (20110714). Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. : Hepatology research : the official journal of the Japan Society of Hepatology.
Chicago
Yasuda Eisuke, Kumada Takashi, Toyoda Hidenori, Kaneoka Yuji, Maeda Atsuyuki, Okuda Seiji, Yoshimi Naoki and Kozawa Osamu. 20110714. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. : Hepatology research : the official journal of the Japan Society of Hepatology.
Harvard
Yasuda E., Kumada T., Toyoda H., Kaneoka Y., Maeda A., Okuda S., Yoshimi N. and Kozawa O. (20110714). Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. : Hepatology research : the official journal of the Japan Society of Hepatology.
MLA
Yasuda Eisuke, Kumada Takashi, Toyoda Hidenori, Kaneoka Yuji, Maeda Atsuyuki, Okuda Seiji, Yoshimi Naoki and Kozawa Osamu. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma. : Hepatology research : the official journal of the Japan Society of Hepatology. 20110714.